These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 32008089)

  • 1. Different response to instrumental tests in relation to cognitive demand after dopaminergic stimulation in previously treated patients with Parkinson's disease.
    Müller T; Harati A
    J Neural Transm (Vienna); 2020 Feb; 127(2):265-272. PubMed ID: 32008089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levodopa improves handwriting and instrumental tasks in previously treated patients with Parkinson's disease.
    Müller T; Harati A
    J Neural Transm (Vienna); 2020 Oct; 127(10):1369-1376. PubMed ID: 32813086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine substitution alters effective connectivity of cortical prefrontal, premotor, and motor regions during complex bimanual finger movements in Parkinson's disease.
    Nettersheim FS; Loehrer PA; Weber I; Jung F; Dembek TA; Pelzer EA; Dafsari HS; Huber CA; Tittgemeyer M; Timmermann L
    Neuroimage; 2019 Apr; 190():118-132. PubMed ID: 29698732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of levodopa infusion on motor activation responses in Parkinson's disease.
    Feigin A; Ghilardi MF; Fukuda M; Mentis MJ; Dhawan V; Barnes A; Ghez CP; Eidelberg D
    Neurology; 2002 Jul; 59(2):220-6. PubMed ID: 12136061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delay of simple reaction time after levodopa intake.
    Müller T; Benz S; Börnke C
    Clin Neurophysiol; 2001 Nov; 112(11):2133-7. PubMed ID: 11682352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tapping and peg insertion after levodopa intake in treated and de novo parkinsonian patients.
    Muller T; Benz S; Przuntek H
    Can J Neurol Sci; 2002 Feb; 29(1):73-7. PubMed ID: 11858540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of habit formation by levodopa in Parkinson's disease.
    Marzinzik F; Wotka J; Wahl M; Krugel LK; Kordsachia C; Klostermann F
    PLoS One; 2011; 6(11):e27695. PubMed ID: 22110725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson's disease.
    Chang FC; Kwan V; van der Poorten D; Mahant N; Wolfe N; Ha AD; Griffith JM; Tsui D; Kim SD; Fung VS
    J Clin Neurosci; 2016 Mar; 25():41-5. PubMed ID: 26777085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: an electrophysiological investigation.
    Prasher D; Findley L
    J Neurol Neurosurg Psychiatry; 1991 Jul; 54(7):603-9. PubMed ID: 1895125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pallidal deep brain stimulation and levodopa treatment on reaction-time performance in Parkinson's disease.
    Schubert T; Volkmann J; Müller U; Sturm V; Voges J; Freund HJ; Von Cramon DY
    Exp Brain Res; 2002 May; 144(1):8-16. PubMed ID: 11976755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensorimotor disinhibition in Parkinson's disease: effects of levodopa.
    Caligiuri MP; Heindel WC; Lohr JB
    Ann Neurol; 1992 Jan; 31(1):53-8. PubMed ID: 1543350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levodopa influences striatal activity but does not affect cortical hyper-activity in Parkinson's disease.
    Martinu K; Degroot C; Madjar C; Strafella AP; Monchi O
    Eur J Neurosci; 2012 Feb; 35(4):572-83. PubMed ID: 22304628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simple movement sequences better correlate to levodopa plasma levels than complex ones.
    Muhlack S; Konietzka S; Woitalla D; Przuntek H; Müller T
    J Neural Transm Suppl; 2004; (68):53-60. PubMed ID: 15354389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of levodopa on motor sequence learning in Parkinson's disease.
    Feigin A; Ghilardi MF; Carbon M; Edwards C; Fukuda M; Dhawan V; Margouleff C; Ghez C; Eidelberg D
    Neurology; 2003 Jun; 60(11):1744-9. PubMed ID: 12796524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of exercise on reactivity and motor behaviour in patients with Parkinson's disease.
    Müller T; Muhlack S
    J Neurol Neurosurg Psychiatry; 2010 Jul; 81(7):747-53. PubMed ID: 20478845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term levodopa test assessed by movement time accurately predicts dopaminergic responsiveness in Parkinson's disease.
    Zappia M; Montesanti R; Colao R; Branca D; Nicoletti G; Aguglia U; Quattrone A
    Mov Disord; 1997 Jan; 12(1):103-6. PubMed ID: 8990062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does cognitive impairment in Parkinson's disease result from non-dopaminergic lesions?
    Pillon B; Dubois B; Cusimano G; Bonnet AM; Lhermitte F; Agid Y
    J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):201-6. PubMed ID: 2703838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decomposing effects of dopaminergic medication in Parkinson's disease on probabilistic action selection--learning or performance?
    Smittenaar P; Chase HW; Aarts E; Nusselein B; Bloem BR; Cools R
    Eur J Neurosci; 2012 Apr; 35(7):1144-51. PubMed ID: 22487043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of the dopaminergic response in Parkinson's disease.
    Müller T; Benz S
    Parkinsonism Relat Disord; 2002 Jan; 8(3):181-6. PubMed ID: 12039429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication impairs probabilistic classification learning in Parkinson's disease.
    Jahanshahi M; Wilkinson L; Gahir H; Dharmaindra A; Lagnado DA
    Neuropsychologia; 2010 Mar; 48(4):1096-103. PubMed ID: 20006629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.